Pere Soler Palacín I have been a pediatrician since 2004, when I completed my residency at HUVH. Since then, I have been responsible for the management of infections and immunodeficiencies in pediatric patients at the hospital. In addition, since 2014, I have been head of the VHIR research group investigating these conditions, and I have been an associate professor of Pediatrics at the UAB since 2011. I obtained my PhD in 2010 and subsequently completed a Master's degree in Pediatric Infectious Diseases at the UAB. I have contributed to more than 300 publications indexed in scientific journals. In 2026, I was appointed Head of the Department of Pediatrics. Institutions of which they are part Head of group Infection and immunity in pediatric patients Vall Hebron Institut de Recerca Head of Department Paediatrics Children's Hospital and Woman's Hospital LinkedIn Twitter Orcid Pere Soler Palacín LinkedIn Twitter Orcid Institutions of which they are part Head of group Infection and immunity in pediatric patients Vall Hebron Institut de Recerca Head of Department Paediatrics Children's Hospital and Woman's Hospital I have been a pediatrician since 2004, when I completed my residency at HUVH. Since then, I have been responsible for the management of infections and immunodeficiencies in pediatric patients at the hospital. In addition, since 2014, I have been head of the VHIR research group investigating these conditions, and I have been an associate professor of Pediatrics at the UAB since 2011. I obtained my PhD in 2010 and subsequently completed a Master's degree in Pediatric Infectious Diseases at the UAB. I have contributed to more than 300 publications indexed in scientific journals. In 2026, I was appointed Head of the Department of Pediatrics.
I graduated in Medicine and Surgery in 1999 with Honours and have been a pediatrician since 2004, when I completed my residency at Vall d’Hebron. I obtained my PhD from the UAB in 2010 and completed a Master's degree in Pediatric Infectious Diseases at the same university in 2014. Since 2004, I have been working as a specialist physician in the Infectious Diseases and Immunodeficiencies Unit at Vall d’Hebron. I headed the unit from 2016 to 2026, when I was appointed Head of the Department of Pediatrics and its Specialties. My clinical work has made me aware of the importance of the appropriate use of antibiotics, which is why I have participated in several initiatives, including pediatric antimicrobial stewardship program (PROA-NEN). Research is essential to advancing the diagnosis and treatment of diseases, and at a hospital such as Vall d’Hebron, it is crucial that research and clinical practice go hand in hand. From 2010 to 2014, I was the principal investigator of the VHIR Research Group on Infections in Immunocompromised Pediatric Patients, which I currently lead. In this field, I have been involved in more than 30 national and international projects, contributed to more than 300 publications in indexed journals, and achieved an h-index of 40. I have also presented more than 300 communications at national and international scientific meetings and supervised 10 doctoral theses.
Projects RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 IP: Pere Soler Palacín Collaborators: Noemí Giménez Sanz, Ariadna Martín Balcells, Miriam Gonzalez Amores, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi Funding agency: EUROPEAN COMMISSION Funding: 525423.93 Reference: RBDCOV_P.SOLER_HE_2021 Duration: 01/12/2021 - 31/08/2025 UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine IP: Pere Soler Palacín Collaborators: Laura Batlle Masó, Miriam Gonzalez Amores, UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards persona, UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards persona Funding agency: EUROPEAN COMMISSION Funding: 163667.5 Reference: UNDINE_P.SOLER_HE_2021 Duration: 01/06/2022 - 31/05/2026 COVID-19, PERFIL INMUNOLÓGICO DE RIESGO IP: - Collaborators: COVID-19, PERFIL INMUNOLÓGICO DE RIESGO, Romina Dieli Crimi, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Arturo Llobell Uriel, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino Funding agency: Instituto de Salud Carlos III Funding: 229000 Reference: COV20/00416 Duration: 08/05/2020 - 08/11/2021 Estudio fase IV, aleatorizado, abierto, controlado para evaluar la terminación temprana del tratamiento con antibioticos en pacientes oncohematológicos con neutropenia febril (e-STOP IP: Pere Soler Palacín Collaborators: Luís Gros Subias, Natalia Ana Mendoza Palomar, Núria Worner Tomasa, Susana Melendo Perez Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI19/01522 Duration: 01/01/2020 - 30/06/2024 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Page 5 … Next page › Last page »